These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33368291)

  • 1. Abrogating GPT2 in triple-negative breast cancer inhibits tumor growth and promotes autophagy.
    Mitra D; Vega-Rubin-de-Celis S; Royla N; Bernhardt S; Wilhelm H; Tarade N; Poschet G; Buettner M; Binenbaum I; Borgoni S; Vetter M; Kantelhardt EJ; Thomssen C; Chatziioannou A; Hell R; Kempa S; Müller-Decker K; Wiemann S
    Int J Cancer; 2021 Apr; 148(8):1993-2009. PubMed ID: 33368291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer.
    Lin CC; Lo MC; Moody R; Jiang H; Harouaka R; Stevers N; Tinsley S; Gasparyan M; Wicha M; Sun D
    Cancer Lett; 2018 Dec; 438():165-173. PubMed ID: 30227220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal GPT2 derived from triple-negative breast cancer cells promotes metastasis by activating BTRC.
    Cui M; Peng J; Zhou Y; Wang X; Cui D
    Thorac Cancer; 2023 Jul; 14(21):2018-2025. PubMed ID: 37287397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
    Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
    Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profilin 2 (PFN2) promotes the proliferation, migration, invasion and epithelial-to-mesenchymal transition of triple negative breast cancer cells.
    Ling Y; Cao Q; Liu Y; Zhao J; Zhao Y; Li K; Chen Z; Du X; Huo X; Kang H; Chen Z
    Breast Cancer; 2021 Mar; 28(2):368-378. PubMed ID: 33047272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways.
    Singel SM; Batten K; Cornelius C; Jia G; Fasciani G; Barron SL; Wright WE; Shay JW
    Breast Cancer Res; 2014 Mar; 16(2):R28. PubMed ID: 24642040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPT2 Is Induced by Hypoxia-Inducible Factor (HIF)-2 and Promotes Glioblastoma Growth.
    Zhang B; Chen Y; Bao L; Luo W
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The delta subunit of the GABA
    Li N; Xu X; Liu D; Gao J; Gao Y; Wu X; Sheng H; Li Q; Mi J
    Theranostics; 2023; 13(4):1355-1369. PubMed ID: 36923530
    [No Abstract]   [Full Text] [Related]  

  • 9. Hyperactivation of mammalian target of rapamycin complex 1 (mTORC1) promotes breast cancer progression through enhancing glucose starvation-induced autophagy and Akt signaling.
    Chen Y; Wei H; Liu F; Guan JL
    J Biol Chem; 2014 Jan; 289(2):1164-73. PubMed ID: 24275666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of the novel histone deacetylase inhibitor YCW1 and radiation induces autophagic cell death through the downregulation of BNIP3 in triple-negative breast cancer cells in vitro and in an orthotopic mouse model.
    Chiu HW; Yeh YL; Wang YC; Huang WJ; Ho SY; Lin P; Wang YJ
    Mol Cancer; 2016 Jun; 15(1):46. PubMed ID: 27286975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serine Biosynthesis Is a Metabolic Vulnerability in IDH2-Driven Breast Cancer Progression.
    Barnabas GD; Lee JS; Shami T; Harel M; Beck L; Selitrennik M; Jerby-Arnon L; Erez N; Ruppin E; Geiger T
    Cancer Res; 2021 Mar; 81(6):1443-1456. PubMed ID: 33500247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamic Pyruvate Transaminase GPT2 Promotes Tumorigenesis of Breast Cancer Cells by Activating Sonic Hedgehog Signaling.
    Cao Y; Lin SH; Wang Y; Chin YE; Kang L; Mi J
    Theranostics; 2017; 7(12):3021-3033. PubMed ID: 28839461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer subtype dictates DNA methylation and ALDH1A3-mediated expression of tumor suppressor RARRES1.
    Coyle KM; Murphy JP; Vidovic D; Vaghar-Kashani A; Dean CA; Sultan M; Clements D; Wallace M; Thomas ML; Hundert A; Giacomantonio CA; Helyer L; Gujar SA; Lee PW; Weaver IC; Marcato P
    Oncotarget; 2016 Jul; 7(28):44096-44112. PubMed ID: 27286452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BECN1-knockout impairs tumor growth, migration and invasion by suppressing the cell cycle and partially suppressing the epithelial-mesenchymal transition of human triple-negative breast cancer cells.
    Wu CL; Zhang SM; Lin L; Gao SS; Fu KF; Liu XD; Liu Y; Zhou LJ; Zhou PK
    Int J Oncol; 2018 Sep; 53(3):1301-1312. PubMed ID: 30015871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The paradox of E-cadherin: role in response to hypoxia in the tumor microenvironment and regulation of energy metabolism.
    Chu K; Boley KM; Moraes R; Barsky SH; Robertson FM
    Oncotarget; 2013 Mar; 4(3):446-62. PubMed ID: 23530113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel oral inhibitor for one-carbon metabolism and checkpoint kinase 1 inhibitor as a rational combination treatment for breast cancer.
    Lee J; Chen X; Wang Y; Nishimura T; Li M; Ishikawa S; Daikoku T; Kawai J; Tojo A; Gotoh N
    Biochem Biophys Res Commun; 2021 Dec; 584():7-14. PubMed ID: 34753066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
    Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
    J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production.
    Guido C; Whitaker-Menezes D; Capparelli C; Balliet R; Lin Z; Pestell RG; Howell A; Aquila S; Andò S; Martinez-Outschoorn U; Sotgia F; Lisanti MP
    Cell Cycle; 2012 Aug; 11(16):3019-35. PubMed ID: 22874531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SANT, a novel Chinese herbal monomer combination, decreasing tumor growth and angiogenesis via modulating autophagy in heparanase overexpressed triple-negative breast cancer.
    Li QW; Zhang GL; Hao CX; Ma YF; Sun X; Zhang Y; Cao KX; Li BX; Yang GW; Wang XM
    J Ethnopharmacol; 2021 Feb; 266():113430. PubMed ID: 33011366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells.
    Ma R; Karthik GM; Lövrot J; Haglund F; Rosin G; Katchy A; Zhang X; Viberg L; Frisell J; Williams C; Linder S; Fredriksson I; Hartman J
    J Natl Cancer Inst; 2017 Mar; 109(3):1-14. PubMed ID: 28376210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.